Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 5836 AL 5850

White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study

Ramirez J, McNeely AA, Scott CJM, Masellis M, Black SE; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2016 Feb;12(2):203-210. doi: 10.1016/j.jalz.2015.06.1886. Epub 2015 Jul 21.

Comparison of automated brain segmentation using a brain phantom and patients with early Alzheimer's dementia or mild cognitive impairment

Fellhauer I, Zöllner FG, Schröder J, Degen C, Kong L, Essig M, Thomann PA, Schad LR.

Psychiatry Res. 2015 Sep 30;233(3):299-305. doi: 10.1016/j.pscychresns.2015.07.011. Epub 2015 Jul 17.

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B.

Lancet Neurol. 2015 Sep;14(9):926-944. doi: 10.1016/S1474-4422(15)00153-2. Epub 2015 Jul 23.

Associations between Verbal Learning Slope and Neuroimaging Markers across the Cognitive Aging Spectrum

Gifford KA, Phillips JS, Samuels LR, Lane EM, Bell SP, Liu D, Hohman TJ, Romano RR 3rd, Fritzsche LR, Lu Z, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2015 Jul;21(6):455-67. doi: 10.1017/S1355617715000430.

An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome

Matsumoto A, Suzuki H, Fukatsu R, Shimizu H, Suzuki Y, Hisanaga K.

Neuropathology. 2016 Feb;36(1):77-87. doi: 10.1111/neup.12232. Epub 2015 Jul 31.

Phonological short-term memory in logopenic variant primary progressive aphasia and mild Alzheimer's disease

Meyer AM, Snider SF, Campbell RE, Friedman RB.

Cortex. 2015 Oct;71:183-9. doi: 10.1016/j.cortex.2015.07.003. Epub 2015 Jul 16.

Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study

Peters R, Collerton J, Granic A, Davies K, Kirkwood T, Jagger C.

J Hypertens. 2015 Oct;33(10):2156-64. doi: 10.1097/HJH.0000000000000653.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease

Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

Sacuiu S, Insel PS, Mueller S, Tosun D, Mattsson N, Jack CR Jr, DeCarli C, Petersen R, Aisen PS, Weiner MW, Mackin RS; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2016 Feb;24(2):126-35. doi: 10.1016/j.jagp.2015.03.006. Epub 2015 Mar 30.

"Sundowning" as a biological phenomenon: current understandings and future directions: an update

Gnanasekaran G.

Aging Clin Exp Res. 2016 Jun;28(3):383-92. doi: 10.1007/s40520-015-0431-3. Epub 2015 Aug 5.

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A.

Nat Rev Neurosci. 2015 Sep;16(9):564-74. doi: 10.1038/nrn3983. Epub 2015 Aug 5.

Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease

Zhang Z, Fang P, Shi M, Zhu Y, Bo P.

Mech Ageing Dev. 2015 Sep;150:20-6. doi: 10.1016/j.mad.2015.08.001. Epub 2015 Aug 4.

Mini-Mental State Examination for the Detection of Alzheimer Disease and Other Dementias in People With Mild Cognitive Impairment

Skorga P, Young CF.

Clin Nurse Spec. 2015 Sep-Oct;29(5):265-7. doi: 10.1097/NUR.0000000000000150.

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW

de Souza Fernandes DP, Canaan Rezende FA, Pereira Rocha G, De Santis Filgueiras M, Silva Moreira PR, Gonçalves Alfenas Rde C.

Nutr Hosp. 2015 Aug 1;32(2):528-33. doi: 10.3305/nh.2015.32.2.9111.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias